Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome

go back to reference Budaj A, Yusuf S, Mehta SR, Fox KA, Tognoni G, Zhao F, Chrolavicius S, Hunt D, Keltai M, Franzosi MG, Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators: Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation. 2002, 106 (13): 1622-1626. 10.1161/01.CIR.0000029926.71825.E2.CrossRefPubMed Budaj A, Yusuf S, Mehta SR, Fox KA, Tognoni G, Zhao F, Chrolavicius S, Hunt D, Keltai M, Franzosi MG, Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators: Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation. 2002, 106 (13): 1622-1626. 10.1161/01.CIR.0000029926.71825.E2.CrossRefPubMed

go back to reference Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C, BASKET-LATE Investigators: Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006, 48 (12): 2584-2591. 10.1016/j.jacc.2006.10.026.CrossRefPubMed Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C, BASKET-LATE Investigators: Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006, 48 (12): 2584-2591. 10.1016/j.jacc.2006.10.026.CrossRefPubMed

go back to reference Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA, Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators: Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001, 358 (9281): 527-533. 10.1016/S0140-6736(01)05701-4.CrossRefPubMed Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA, Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators: Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001, 358 (9281): 527-533. 10.1016/S0140-6736(01)05701-4.CrossRefPubMed

go back to reference Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001, 345 (7): 494-502.CrossRefPubMed Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001, 345 (7): 494-502.CrossRefPubMed

go back to reference Airoldi F, Colombo A, Morici N, Latib A, Cosgrave J, Buellesfeld L, Bonizzoni E, Carlino M, Gerckens U, Godino C, Melzi G, Michev I, Montorfano M, Sangiorgi GM, Qasim A, Chieffo A, Briguori C, Grube E: Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation. 2007, 116 (7): 745-754. 10.1161/CIRCULATIONAHA.106.686048.CrossRefPubMed Airoldi F, Colombo A, Morici N, Latib A, Cosgrave J, Buellesfeld L, Bonizzoni E, Carlino M, Gerckens U, Godino C, Melzi G, Michev I, Montorfano M, Sangiorgi GM, Qasim A, Chieffo A, Briguori C, Grube E: Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation. 2007, 116 (7): 745-754. 10.1161/CIRCULATIONAHA.106.686048.CrossRefPubMed

go back to reference Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Zidar JP, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011, 57 (19): e215-e367. 10.1016/j.jacc.2011.02.011.CrossRefPubMed Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Zidar JP, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011, 57 (19): e215-e367. 10.1016/j.jacc.2011.02.011.CrossRefPubMed

go back to reference Taylor J: 2012 ESC Guidelines on acute myocardial infarction (STEMI). Eur Heart J. 2012, 33 (20): 2501-2502.CrossRefPubMed Taylor J: 2012 ESC Guidelines on acute myocardial infarction (STEMI). Eur Heart J. 2012, 33 (20): 2501-2502.CrossRefPubMed

go back to reference Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, ESC Committee for Practice Guidelines: ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011, 32 (23): 2999-3054.CrossRefPubMed Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, ESC Committee for Practice Guidelines: ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011, 32 (23): 2999-3054.CrossRefPubMed

go back to reference Camenzind E, Steg PG, Wijns W: Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation. 2007, 115 (11): 1440-1455. 10.1161/CIRCULATIONAHA.106.666800. discussion 55CrossRefPubMed Camenzind E, Steg PG, Wijns W: Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation. 2007, 115 (11): 1440-1455. 10.1161/CIRCULATIONAHA.106.666800. discussion 55CrossRefPubMed

go back to reference Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L: Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007, 356 (10): 1009-1019. 10.1056/NEJMoa067722.CrossRefPubMed Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L: Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007, 356 (10): 1009-1019. 10.1056/NEJMoa067722.CrossRefPubMed

go back to reference Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ, CHARISMA Investigators: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006, 354 (16): 1706-1717. 10.1056/NEJMoa060989.CrossRefPubMed Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ, CHARISMA Investigators: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006, 354 (16): 1706-1717. 10.1056/NEJMoa060989.CrossRefPubMed

go back to reference Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K, j-Cypher Registry Investigators: Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009, 119 (7): 987-995. 10.1161/CIRCULATIONAHA.108.808311.CrossRefPubMed Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K, j-Cypher Registry Investigators: Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009, 119 (7): 987-995. 10.1161/CIRCULATIONAHA.108.808311.CrossRefPubMed

go back to reference Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SW, Park SJ: Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents. JACC Cardiovasc Interv. 2008, 1 (5): 494-503. 10.1016/j.jcin.2008.06.011.CrossRefPubMed Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SW, Park SJ: Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents. JACC Cardiovasc Interv. 2008, 1 (5): 494-503. 10.1016/j.jcin.2008.06.011.CrossRefPubMed

go back to reference Steinhubl SR, Berger PB, Mann JT, Fry ET, DeLago A, Wilmer C, Topol EJ, CREDO Investigators. Clopidogrel for the Reduction of Events During Observation: Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002, 288 (19): 2411-2420. 10.1001/jama.288.19.2411.CrossRefPubMed Steinhubl SR, Berger PB, Mann JT, Fry ET, DeLago A, Wilmer C, Topol EJ, CREDO Investigators. Clopidogrel for the Reduction of Events During Observation: Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002, 288 (19): 2411-2420. 10.1001/jama.288.19.2411.CrossRefPubMed

go back to reference Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM: Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007, 297 (2): 159-168. 10.1001/jama.297.2.joc60179.CrossRefPubMed Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM: Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007, 297 (2): 159-168. 10.1001/jama.297.2.joc60179.CrossRefPubMed

go back to reference Banerjee S, Varghese C, Samuel J, Weideman RA, Little BB, Kelly KC, Rao SV, Reilly RF, Brilakis ES: Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality. Am J Cardiol. 2008, 102 (9): 1159-1162. 10.1016/j.amjcard.2008.06.058.CrossRefPubMed Banerjee S, Varghese C, Samuel J, Weideman RA, Little BB, Kelly KC, Rao SV, Reilly RF, Brilakis ES: Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality. Am J Cardiol. 2008, 102 (9): 1159-1162. 10.1016/j.amjcard.2008.06.058.CrossRefPubMed

go back to reference Ernst FR, Johnston S, Curkendall S, Mozaffari E, Stemkowski S: Effect of early clopidogrel discontinuation on rehospitalization in acute coronary syndrome: results from two distinct patient populations. Am J Health Syst Pharm. 2011, 68 (11): 1015-1024. 10.2146/ajhp100455.CrossRefPubMed Ernst FR, Johnston S, Curkendall S, Mozaffari E, Stemkowski S: Effect of early clopidogrel discontinuation on rehospitalization in acute coronary syndrome: results from two distinct patient populations. Am J Health Syst Pharm. 2011, 68 (11): 1015-1024. 10.2146/ajhp100455.CrossRefPubMed

go back to reference Wiederkehr D, Ogbonnaya A, Casciano R, Makenbaeva D, Mozaffari E, Corbelli J: Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population. Curr Med Res Opin. 2009, 25 (9): 2327-2334. 10.1185/03007990903156087.CrossRefPubMed Wiederkehr D, Ogbonnaya A, Casciano R, Makenbaeva D, Mozaffari E, Corbelli J: Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population. Curr Med Res Opin. 2009, 25 (9): 2327-2334. 10.1185/03007990903156087.CrossRefPubMed

go back to reference Yusuf I, Djojosubroto MW, Ikawati R, Lum K, Kaneko A, Marzuki S: Ethnic and geographical distributions of CYP2C19 alleles in the populations of Southeast Asia. Adv Exp Med Biol. 2003, 531: 37-46. 10.1007/978-1-4615-0059-9_3.CrossRefPubMed Yusuf I, Djojosubroto MW, Ikawati R, Lum K, Kaneko A, Marzuki S: Ethnic and geographical distributions of CYP2C19 alleles in the populations of Southeast Asia. Adv Exp Med Biol. 2003, 531: 37-46. 10.1007/978-1-4615-0059-9_3.CrossRefPubMed

go back to reference Wiederkehr D, Berenson K, Casciano R, Stern L, Makenbaeva D, Mozaffari E, Lamerato L, Corbelli J: Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health network. Curr Med Res Opin. 2009, 25 (9): 2317-2325. 10.1185/03007990903156061.CrossRefPubMed Wiederkehr D, Berenson K, Casciano R, Stern L, Makenbaeva D, Mozaffari E, Lamerato L, Corbelli J: Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health network. Curr Med Res Opin. 2009, 25 (9): 2317-2325. 10.1185/03007990903156061.CrossRefPubMed